You are here

Price rise for anti-allergy EpiPen sparks furore

Fivefold price hike of epinephrine injector makes it unaffordable to many US sufferers


A FIVEFOLD price hike for EpiPen, which allergy sufferers use to counteract life-threatening reactions, has made Mylan the newest drugmaker to come under attack in the United States for profiteering.

Mylan Pharmaceuticals, which holds a near-monopoly position on the...

Market voices on: